Predict is an innovative company in the healthcare sector: it markets ultrasound and radiology systems and develops technologies that help people live and work better. Predict is authorised distributor of GE Healthcare for the Puglia region. Predict’s strategy is based on: • people, • customer focus • services of excellence. Our strengths are: • INNOVATION: Technologies, projects and skills: everything is evolving. The aim is always to stay one step ahead, to accelerate change. • ORGANISATION: The division into areas makes it possible to optimise operational processes and increase the efficiency of the entire company, enhancing competitiveness and results. • CUSTOMER FOCUS: Speed of response, after-sales service, exhibition spaces to introduce and test products: Predict is always at the customer’s side. • RELIABILITY: Efficient services, financial solidity, respect for deadlines, partnerships with companies and research institutes: this is why Predict grows with its customers every year. Predict is a constantly evolving reality in line with the times and technologies, which invests in research and development to transform visionary ideas into concrete and innovative projects. In 2017 Predict engineers develop Optip, the new communication and collaboration tool based on holopresence. Optip is the platform that enables advanced video calling and sharing of knowledge and skills between distant users through the potential of augmented reality. Application scenarios: • operating room surgeries; • tele-ecography; • emergency-urgency; • innovative education. Optip is a patented technology, European patent number US11122164 and all products comply with European Directive 93/42/EEC and are CE-marked. In 2018 Predict engineers develop Aphel, the artificial intelligence platform dedicated to hospitals, and Mistral, the technology for diagnostic monitoring based on breath analysis. Aphel is the artificial intelligence platform that integrates humanoid robots to support patients and healthcare staff in hospitals. The aim is to improve the quality of the services provided and transform the hospital into a 4.0 space. Mistral is the innovative breath analysis-based technology that enables early, non-invasive diagnosis and metabolic monitoring. Born out of the collaboration with the University of Bari and Predict, Mistral offers benefits to patients, doctors and the healthcare system. Mistral is a patented technology, European patent number 3873347 and all products comply with European Directive 93/42/EEC and are CE-marked.
Sign Up 
